Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» VX-770
VX-770
FDA Grants Priority Review for KALYDECO™ (ivacaftor), the First Potential Medicine to Target the Underlying Cause of Cystic Fibrosis
Yahoo
Thu, 12/15/11 - 11:02 am
FDA
Kalydeco
Vertex
VX-770
cystic fibrosis
Vertex Seeks FDA Green Light for Cystic Fibrosis Drug, Second Potential Hit of Big Year
Xconomy
Wed, 10/19/11 - 10:39 am
Vertex
FDA
cystic fibrosis
ivacaftor
Kalydeco
VX-770
Can Vertex Catch Lightening in a Bottle Again?
Seeking Alpha
Wed, 09/21/11 - 11:15 pm
Vertex
Incivek
hepatitis C
CF
cystic fibrosis
VX-770
Vertex: First Drugs Ever to Target Root Cause of Cystic Fibrosis
Seeking Alpha
Mon, 06/13/11 - 06:09 pm
Vertex Pharmaceuticals
cystic fibrosis
CF
VX-770
Exelixis
It's a Numbers Game With Vertex
Motley Fool
Thu, 06/9/11 - 07:44 pm
Vertex Pharmaceuticals
CF
cystic fibrosis
VX-770
Vertex's promising CF drug combo clears first hurdle in Ph2
Fierce Biotech
Thu, 06/9/11 - 09:20 am
CF
cystic fibrosis
Vertex Pharmaceuticals
VX-770
Vertex Notches Another Victory
Minyanville
Tue, 03/29/11 - 11:36 am
Vertex Pharmaceuticals
cystic fibrosis
VX-770
Vertex's Treatment for Cystic Fibrosis
Bloomberg Businessweek
Fri, 03/18/11 - 09:03 am
cystic fibrosis
Vertex Pharmaceuticals
VX-770
No Serendipity Involved in Vertex's Achievements
Seeking Alpha
Fri, 03/4/11 - 10:37 am
Vertex Pharmaceuticals
VX-770
cystic fibrosis
Vertex cystic fibrosis drug meets study goals
Yahoo/AP
Wed, 02/23/11 - 07:53 am
Vertex Pharmaceuticals
cystic fibrosis
VX-770